Literature DB >> 11807318

Unfavourable interaction of amprenavir and lopinavir in combination with ritonavir?

Stefan Mauss, Guenther Schmutz, Dieter Kuschak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807318     DOI: 10.1097/00002030-200201250-00023

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetic enhancement of protease inhibitor therapy.

Authors:  Jennifer R King; Heather Wynn; Richard Brundage; Edward P Acosta
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.

Authors:  Elena Seminari; Monica Guffanti; Paola Villani; Nicola Gianotti; Maria Cusato; Giuliana Fusetti; Andrea Galli; Antonella Castagna; Mario Regazzi; Adriano Lazzarin
Journal:  Eur J Clin Pharmacol       Date:  2005-07-23       Impact factor: 2.953

Review 3.  Management of HIV-infected patients with multidrug-resistant virus.

Authors:  Marianne Harris; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

Review 4.  Saquinavir: a review of its use in boosted regimens for treating HIV infection.

Authors:  Greg L Plosker; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.

Authors:  Cédric Arvieux; Olivier Tribut
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virus.

Authors:  Ighovwerha Ofotokun; Edward P Acosta; Jeffrey L Lennox; Yi Pan; Kirk A Easley
Journal:  Pharmacotherapy       Date:  2008-01       Impact factor: 4.705

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.